Skip to main content

Fulvestrant

NDC 70121-1463 · Amneal Pharmaceuticals LLC

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameFulvestrant
Dosage formINJECTION, SOLUTION
RouteINTRAMUSCULAR
Active ingredient(s)FULVESTRANT
Strength250 mg/5mL
Pharmacologic classEstrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]
Marketing categoryANDA

Packages

70121-1463-9 — 2 SYRINGE, GLASS in 1 CARTON (70121-1463-9) / 5 mL in 1 SYRINGE, GLASS (70121-1463-1)

70121-1463-2 — 2 SYRINGE, GLASS in 1 CARTON (70121-1463-2) / 5 mL in 1 SYRINGE, GLASS (70121-1463-3)

Billed under HCPCS

J9395 — Injection, fulvestrant, 25 mg Medicare Part B payment limit (ASP + 6%): $5.28

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0781-9055 — Fulvestrant, 16714-070 — fulvestrant, 16729-436 — Fulvestrant, 25021-471 — fulvestrant, 43598-262 — Fulvestrant, 55150-394 — Fulvestrant, 62332-650 — Fulvestrant, 63323-715 — Fulvestrant, 68001-484 — Fulvestrant, 68001-522 — Fulvestrant, 68001-626 — Fulvestrant, 68462-317 — Fulvestrant, 70700-284 — fulvestrant, 70710-1688 — fulvestrant, 70771-1626 — fulvestrant, 70860-211 — fulvestrant, 71288-555 — Fulvestrant, 71731-6121 — fulvestrant, 83634-203 — fulvestrant, 83831-159 — fulvestrant, +3 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.